United Therap

UTHR

541.5100.27% ( +1.480 )

Closed: Oct 15, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is 17.72, above the reasonable range, cheaper than 10.71% of the time in the past 3 years, and the industry ranks 37/604, the industry Median -1.93.

17.72xP/E

Stock price$541.51Earnings per share$30.56

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

020406080

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
AMGNUSAmgen	26.84x	10.68%	$234.65B
VRTXUSVertex Pharma	29.27x	2.31%	$128.95B
REGNUSRegeneron Pharma	18.94x	10.39%	$81.99B
GMABUSGenmab A/S	29.51x	28.51%	$23.26B
UTHRUSUnited Therap	17.72x	5.07%	$23.23B
EXELUSExelixis	18.09x	16.24%	$15.57B
ASNDUSAscendis Pharmac	17.34x	467.42%	$14.91B
NBIXUSNeurocrine Biosciences	19.73x	50.56%	$13.92B
TGTXUSTG Therap	19.42x	64.59%	$8.57B
PBYIUSPuma BioTech	20.32x	37.70%	$543.04M
KMDAUSKamada	20.31x	36.43%	$451.87M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.